Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis

Annals of the Rheumatic Diseases

Volumn 62, Issue 12, 2003, Pages 1230-1233

  Lamprecht, P ^a   Lerin Lozano, C ^a   Merz, H ^a   Dennin, R H ^a   Gause, A ^a   Voswinkel, J ^a   Peters, S O ^a   Gutzeit, O ^a   Arlt, A C ^b   Solbach, W ^a   Gross, W L ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Rheumaklinik Bad Bramstedt ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; CD20 ANTIGEN; CYCLOPHOSPHAMIDE; PREDNISOLONE; REBETROL; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; RITUXIMAB;

ADULT; ARTHRALGIA; ARTICLE; B LYMPHOCYTE; BONE MARROW BIOPSY; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; CRYOGLOBULINEMIC VASCULITIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; NONHODGKIN LYMPHOMA; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN TARGETING; PURPURA; SYMPTOM; TREATMENT FAILURE; TREATMENT OUTCOME; VASCULITIS;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CRYOGLOBULINEMIA; DRUG RESISTANCE, NEOPLASM; DRUG RESISTANCE, VIRAL; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; REMISSION INDUCTION; RIBAVIRIN; VASCULITIS;

EID: 10744226311     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2002.004929     Document Type: Article

References (15)

1. Ferri C, La Civita L, Longombardo G, Zignego AL, Pasero G. Mixed cryoglobulinemia: a cross-road between autoimmune and lymphoproliferative disorders. Lupus 1998;7:275-9.
2. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-5.
3. Lamprecht P, Gause A, Gross WL. Cryoglobulinemic vasculitis. Arthritis Rheum 1999;42:2507-16.
4. Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol 2002;55:4-13.
5. Dammacco F, Sansonno D, Piccoli C, Racanelli V, D'Amore FP, Lauletta G. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy. Semin Liver Dis 2000;20:143-57.
6. Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996;87:4296-301.
7. Ferri C, Monti M, La Civita L, Careccia G, Mazzaro C, Longombardo G, et al. Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinemia. Eur J Clin Invest 1994;24:781-4.
8. Mazzaro C, Franzin F, Tulissi P, Pussini E, Crovatto M, Carniello GS, et al. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to α-Interferon therapy. Cancer 1996,77:2604-13.
9. Donada C, Crucitti A, Donadon V, Chemello L, Alberti A. Interferon α and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia. Blood 1998;92:2983-4.
10. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974;57:775-88.
11. Luqmani RA. Assessing disease activity in systemic vasculitides. Curr Opin Rheumatol 2002;14:23-8.
12. Zaja F, Russo D, Fuga G, Patriarca F, Ermacora A, Baccarani M. Rituximab for the treatment of type II mixed cryoglobulinemia. Haematologica 1999;84:1157-8.
13. Matsubara T, Sumazaki R, Shin K, Nagai Y, Takita H. Genotyping of hepatitis C virus: coinfection by multiple genotypes detected in children with chronic post-transfusion hepatitis C. J Pediatr Gastroenterol Nutr 1996;22:79-84.
14. Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002;347:89-94.
15. Riley JK, Sliwkowski MX. CD20: a gene in search of a function. Semin Oncol 2000;27(suppl6):17-24.